SHPH
NASDAQShuttle Pharmaceuticals
$5.55
+0.84 (+17.83%)
2026-10-08 00:00
Healthcare
Drug Manufacturers - Specialty & Generic
--
--
Short Interest (1 Year)
% of Volume Sold ShortMarket Cap
$19.9M
P/E Ratio
0.4
52W Low
52W High
$0.38
$6.15
Volume
281K
About Shuttle Pharmaceuticals
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Employees
2
Website
shuttlepharma.com
Financial Highlights
Annual
Quarterly
| Year | Revenue | Op Margin | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2025 | N/A | N/A% | -$11.7M | -$9.5M |
| 2024 | N/A | N/A% | -$9.1M | -$7.3M |
| 2023 | N/A | N/A% | -$6.6M | -$5.6M |
| 2022 | N/A | N/A% | -$5.0M | -$2.7M |
| 2021 | N/A | N/A% | -$1.2M | -$300K |
| 2026 Q2 | N/A | N/A% | -$3.1M | -$532K |
| 2026 Q1 | N/A | N/A% | -$2.2M | -$2.4M |
| 2025 Q4 | N/A | N/A% | -$2.6M | -$973K |
| 2025 Q3 | N/A | N/A% | -$2.3M | -$2.6M |
| 2025 Q2 | N/A | N/A% | -$3.7M | -$3.4M |
| 2025 Q1 | N/A | N/A% | -$3.1M | -$2.5M |
| 2024 Q4 | $6K | -30917.3% | -$1.6M | -$2.7M |
| 2024 Q3 | N/A | N/A% | -$3.8M | -$2.0M |